Dr. Belz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1830 E Monument St
Fl 5
Baltimore, MD 21287Phone+1 410-550-2304
Summary
- Dr. Belz is a pulmonologist in Baltimore, MD and is affiliated with the Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He is the director of bronchiectasis at the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis and a member of the Johns Hopkins Breathe Center, which is dedicated to studying the effects of environment on lung health and specific lung diseases throughout life. He specializes in pulmonary and critical care medicine and is experienced in bronchiectasis, chronic obstructive pulmonary disease (COPD), critical care medicine, and nontuberculous mycobacteria. He received his medical degree and master of public health from the University of Kansas School of Medicine, completed internal medicine residency and chief residency at Boston University, and fellowship in pulmonary and critical care medicine at Johns Hopkins University.
Education & Training
- Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2022
- Boston University Medical CenterResidency, Internal Medicine, 2014 - 2017
- University of Kansas School of MedicineClass of 2014
Certifications & Licensure
- MD State Medical License 2019 - 2026
- VA State Medical License 2024 - 2026
- MA State Medical License 2014 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Longitudinal anemia status and risk for adverse outcomes in former smokers with COPD.Yukiko Kunitomo, Han Woo, Aparna Balasubramanian, Ashraf Fawzy, Cheng Ting Lin
Respiratory Research. 2024-12-19 - Call to Action: How Can We Promote the Development of New Pharmacologic Treatments in Chronic Obstructive Pulmonary Disease?Daniel C Belz, Nirupama Putcha, Patricia Alupo, Trishul Siddharthan, Aaron Baugh
American Journal of Respiratory and Critical Care Medicine. 2024-12-01 - 1 citationsEfficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model oflung disease.Elisa H Ignatius, Binayak Rimal, Chandra M Panthi, Daniel C Belz, Christopher K Lippincott
Msphere. 2024-07-30
Press Mentions
- Chronic Obstructive Pulmonary Diseases: Journal of the COPD FoundationNovember 17th, 2023
- Chronic Obstructive Pulmonary Diseases: Journal of the COPD FoundationMay 6th, 2024
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: